Total submissions: 20
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000122196 | SCV000169096 | benign | not specified | 2013-10-01 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000130763 | SCV000185655 | benign | Hereditary cancer-predisposing syndrome | 2014-12-03 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genetic Services Laboratory, |
RCV000122196 | SCV000249203 | benign | not specified | 2021-08-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001080484 | SCV000261866 | benign | Tuberous sclerosis 1 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000122196 | SCV000303868 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Eurofins Ntd Llc |
RCV000122196 | SCV000333780 | likely benign | not specified | 2015-08-04 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000297382 | SCV000478183 | likely benign | Isolated focal cortical dysplasia type II | 2018-09-25 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV001080484 | SCV000478184 | likely benign | Tuberous sclerosis 1 | 2018-09-25 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000034609 | SCV000696608 | benign | not provided | 2016-08-31 | criteria provided, single submitter | clinical testing | Variant Summary: The c.3103G>A (p.Gly1035Ser) in TSC1 gene is a missense change that involves a non-conserved nucleotide and 3/4 in silico programs predicting a "benign" outcome. The variant of interest was observed in controls with an allele frequency of 0.0014 (170/119052chrs tested) which exceeds the predicted maximum expected allele frequency for a pathogenic variant in this gene (0.0025). The variant of interest has been reported in multiple affected individuals in cis with a pathogenic variant (Nellist, 2009, TSC1 db).In the functional studies the G1035S had similar activities as wt (Nellist, 2009). In addition, multiple reputable databases/clinical laboratories and publications cite the variant with a classification of "Neutral/likely benign." Therefore, taking all available lines of evidence into consideration, the variant of interest is classified as a Benign. |
Institute for Clinical Genetics, |
RCV000034609 | SCV002009242 | uncertain significance | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001080484 | SCV002040015 | benign | Tuberous sclerosis 1 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000130763 | SCV002531419 | benign | Hereditary cancer-predisposing syndrome | 2020-09-24 | criteria provided, single submitter | curation | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000122196 | SCV002774055 | benign | not specified | 2021-08-25 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000034609 | SCV003917725 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | TSC1: BP4, BS1 |
Color Diagnostics, |
RCV001080484 | SCV004360799 | benign | Tuberous sclerosis 1 | 2022-10-09 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000034609 | SCV004563124 | benign | not provided | 2023-10-26 | criteria provided, single submitter | clinical testing | |
Biesecker Lab/Clinical Genomics Section, |
RCV000034609 | SCV000043507 | probably not pathogenic | not provided | 2012-07-13 | no assertion criteria provided | research | Converted during submission to Likely benign. |
Tuberous sclerosis database |
RCV000054850 | SCV000066052 | not provided | Tuberous sclerosis syndrome | no assertion provided | curation | ||
ITMI | RCV000122196 | SCV000086415 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000122196 | SCV001966233 | benign | not specified | no assertion criteria provided | clinical testing |